Vol 2004, No 52 (2004)

Table of Contents

Research & Development

Biogen Idec and Sunesis Sign Small Molecule Cancer Agreement Abstract pdf
Business Review Editor

Licensing

Transition Licenses Diabetes Regenerative Therapy to Novo Nordisk Abstract pdf
Business Review Editor
Pfizer Licenses Nitric Oxide-Donating Compounds from NicOx Abstract pdf
Business Review Editor

General

MGI Pharma’s US$122 M Oncology Spree Abstract
Business Review Editor

Company Profile

NicOx SA Abstract pdf
Business Review Editor

Distribution & Marketing

New Distributor for Cedax® in the US Abstract pdf
Business Review Editor

Business Commentaries

Royalty Rates - What is There to Hide? html
Fintan Walton

Deal Trackers

Ampligen (polyI:polyC12U) Abstract pdf
Business Review Editor

Mergers & Acquisitions

Mylan to Acquire King for US$4 B Abstract
Business Review Editor
Pfizer Sells Two of its Generics Units Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.